Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues.

Grimm KE, O'Malley DP.

Ann Diagn Pathol. 2018 Oct 2;38:6-10. doi: 10.1016/j.anndiagpath.2018.09.014. [Epub ahead of print] Review.

PMID:
30380402
2.

Burkitt lymphoma in Iraqi children: A distinctive form of sporadic disease with high incidence of EBV+ cases and more frequent expression of MUM1/IRF4 protein in cases with head and neck presentation.

Uccini S, Al-Jadiry MF, Cippitelli C, Talerico C, Scarpino S, Al-Darraji AF, Al-Badri SAF, Alsaadawi AR, Al-Hadad SA, Ruco L.

Pediatr Blood Cancer. 2018 Dec;65(12):e27399. doi: 10.1002/pbc.27399. Epub 2018 Sep 11.

PMID:
30207048
3.

High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma.

Ok CY, Medeiros LJ, Thakral B, Tang G, Jain N, Jabbour E, Pierce SA, Konoplev S.

Mod Pathol. 2018 Sep 4. doi: 10.1038/s41379-018-0112-9. [Epub ahead of print]

PMID:
30181564
4.

An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.

Romero-Masters JC, Ohashi M, Djavadian R, Eichelberg MR, Hayes M, Bristol JA, Ma S, Ranheim EA, Gumperz J, Johannsen EC, Kenney SC.

PLoS Pathog. 2018 Aug 20;14(8):e1007221. doi: 10.1371/journal.ppat.1007221. eCollection 2018 Aug.

5.

Contribution of Immunocytochemistry to the Diagnosis of Usual and Unusual Lymphoma Cases.

Das DK.

J Cytol. 2018 Jul-Sep;35(3):163-169. doi: 10.4103/JOC.JOC_42_18.

6.

Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation's 2017 classification.

Szumera-Ciećkiewicz A, Rymkiewicz G, Grygalewicz B, Jesionek-Kupnicka D, Gruchała A, Ziarkiewicz-Wróblewska B, Gałązka K, Reszeć J, Borg K, Prochorec-Sobieszek M.

Pol J Pathol. 2018;69(1):1-19. doi: 10.5114/pjp.2018.75332. Review.

7.

[Exceptional etiology of acute renal: Burkitt's lymphoma].

Dial C, Doh K, Thiam I, Faye M, Woto-Gaye G.

Nephrol Ther. 2018 Jun;14(4):237-239. doi: 10.1016/j.nephro.2017.11.005. French.

PMID:
29422322
8.

A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.

Rymkiewicz G, Grygalewicz B, Chechlinska M, Blachnio K, Bystydzienski Z, Romejko-Jarosinska J, Woroniecka R, Zajdel M, Domanska-Czyz K, Martin-Garcia D, Nadeu F, Swoboda P, Rygier J, Pienkowska-Grela B, Siwicki JK, Prochorec-Sobieszek M, Salaverria I, Siebert R, Walewski J.

Mod Pathol. 2018 May;31(5):732-743. doi: 10.1038/modpathol.2017.186. Epub 2018 Jan 12.

PMID:
29327714
9.

[Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].

Yin WJ, Zhu X, Yang HY, Sun WY, Wu MJ.

Zhonghua Bing Li Xue Za Zhi. 2018 Jan 8;47(1):32-38. doi: 10.3760/cma.j.issn.0529-5807.2018.01.007. Chinese.

PMID:
29325248
10.

Primary effusion lymphoma in Taiwan shows two distinctive clinicopathological subtypes with rare human immunodeficiency virus association.

Chen BJ, Wang RC, Ho CH, Yuan CT, Huang WT, Yang SF, Hsieh PP, Yung YC, Lin SY, Hsu CF, Su YZ, Kuo CC, Chuang SS.

Histopathology. 2018 May;72(6):930-944. doi: 10.1111/his.13449. Epub 2018 Feb 14.

PMID:
29206290
11.

High expression of Fibronectin 1 suppresses apoptosis through the NF-κB pathway and is associated with migration in nasopharyngeal carcinoma.

Wang J, Deng L, Huang J, Cai R, Zhu X, Liu F, Wang Q, Zhang J, Zheng Y.

Am J Transl Res. 2017 Oct 15;9(10):4502-4511. eCollection 2017.

12.

B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients.

Li Y, Gupta G, Molofsky A, Xie Y, Shihabi N, McCormick J, Jaffe ES.

Am J Surg Pathol. 2018 Feb;42(2):269-276. doi: 10.1097/PAS.0000000000000982.

PMID:
29112016
13.

Primary Cutaneous Follicle Centre Lymphoma with Hodgkin and Reed-Sternberg Like Cells: A Case Report and Review of the Literature.

Aldarweesh FA, Treaba DO.

Case Rep Hematol. 2017;2017:9549428. doi: 10.1155/2017/9549428. Epub 2017 Sep 26.

15.

An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation.

Pei Y, Banerjee S, Jha HC, Sun Z, Robertson ES.

PLoS Pathog. 2017 Jul 24;13(7):e1006500. doi: 10.1371/journal.ppat.1006500. eCollection 2017 Jul.

17.

Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection.

Price AM, Dai J, Bazot Q, Patel L, Nikitin PA, Djavadian R, Winter PS, Salinas CA, Barry AP, Wood KC, Johannsen EC, Letai A, Allday MJ, Luftig MA.

Elife. 2017 Apr 20;6. pii: e22509. doi: 10.7554/eLife.22509.

18.

HHV8/EBV Coinfection Lymphoproliferative Disorder: Rare Entity with a Favorable Outcome.

Bacha D, Chelly B, Kilani H, Charfi L, Douggaz A, Chatti S, Chelbi E.

Case Rep Hematol. 2017;2017:1578429. doi: 10.1155/2017/1578429. Epub 2017 Feb 9.

19.

B-cell posttransplant lymphoproliferative disorder isolated to the central nervous system is Epstein-Barr virus positive and lacks p53 and Myc expression by immunohistochemistry.

Sundin A, Grzywacz BJ, Yohe S, Linden MA, Courville EL.

Hum Pathol. 2017 Mar;61:140-147. doi: 10.1016/j.humpath.2016.12.007. Epub 2016 Dec 16.

PMID:
27993575
20.

EBV-associated but HHV8-unrelated double-hit effusion-based lymphoma.

Chen BJ, Chen DY, Kuo CC, Chuang SS.

Diagn Cytopathol. 2017 Mar;45(3):257-261. doi: 10.1002/dc.23638. Epub 2016 Nov 26.

PMID:
27888664

Supplemental Content

Loading ...
Support Center